Escherichia coli K1 is the most common Gram-negative organism causing neonatal meningitis, but it is incompletely understood how E. coli K1 crosses the blood-brain barrier. We have previously identified several E. coli determinants contributing to invasion of brain microvascular endothelial cells (BMEC) in vitro, which include OmpA and IbeB. In the present study, we constructed a mutant (E98) by deleting only OmpA (isogenic OmpA deletion mutant) from E. coli K1 strain RS218 (018:K1:H7) and also an isogenic OmpA deletion mutant from the ibeB-deleted mutant (IB7D5) of strain RS218. As expected, the ompA and ibeB deletion mutants, E98 and IB7D5, respectively, were less invasive in BMEC in vitro compared with the parent strain. More importantly, their abilities to penetrate the blood-brain barrier were significantly less than those of the parent strain in the experimental hematogenous E. coli meningitis model. The combined ompA-and ibeB-deleted mutant, however, behaved similarly compared with its single-gene deletion mutants (E98 and IB7D5) The mortality and morbidity associated with neonatal meningitis remain significant despite advances in antimicrobial chemotherapy and supportive care (1, 2). Inadequate knowledge of the pathogenesis and pathophysiology of this disease has contributed to this poor outcome. For example, most cases of Escherichia coli meningitis develop as a result of hematogenesis spread, but it is not completely understood how circulating E. coli crosses the blood-brain barrier (3).
The mortality and morbidity associated with neonatal meningitis remain significant despite advances in antimicrobial chemotherapy and supportive care (1, 2) . Inadequate knowledge of the pathogenesis and pathophysiology of this disease has contributed to this poor outcome. For example, most cases of Escherichia coli meningitis develop as a result of hematogenesis spread, but it is not completely understood how circulating E. coli crosses the blood-brain barrier (3) .
Our previous investigations using in vitro and in vivo models of the blood-brain barrier have indicated that successful traversal of the blood-brain barrier by circulating E. coli K1 requires 1) a high level of bacteremia and 2) invasion of BMEC (3) . This was shown by the demonstration that a high degree of bacteremia is necessary but not sufficient for the development of meningitis by E. coli and that invasion of BMEC is a prerequisite for E. coli penetration into the CNS in vivo. Our previous investigations have also identified that specific microbial determinants such as OmpA, Ibe proteins, TraJ, CNF1, and AslA are required for invasion of BMEC in vitro and crossing of the blood-brain barrier in vivo (3) (4) (5) (6) (7) (8) (9) (10) (11) , but it is unclear why these E. coli determinants are necessary for penetration into the CNS. The contributions of Ibe proteins, TraJ, CNF1, and AslA to invasion of BMEC have been identified by using their respective isogenic mutants of E. coli K1 strain RS218 (or E44), whereas OmpA was previously identified by using the OmpA deletion mutant, strain E91, which was constructed from strain E44 by P1 transduction (5) .
In the present study, we constructed the isogenic ompA deletion mutant from the parent E. coli K1 strain E44 as well as from the ibeB deletion mutant and examined their ability to r gene was cleaved from pACYC184 (New England BioLabs) and used to replace the 100-bp AccI fragment (one of the AccI sites is on the vector) in the middle of the ⌬ompA DNA in pK-⌬omp to produce pK-⌬ompCm. A 0.7-kb DNA containing the R6K replication origin and an oriT sequence were purified from pBSL238 (14) , and used to replace the 0.8-kb HindIII-XbaI fragment containing the replication origin of pK-⌬ompCm. The plasmid, named p⌬ompCm238, was then transferred into E. coli strain E44 by conjugation as previously described (6, 7) using the E. coli SM10pir as the host. The Cm r Rif r transconjugants were selected and tested for Km resistance. Three of 60 colonies were found to be Km s . These colonies were examined by PCR using Omp3 and Omp3R (Table 2) to verify the deletion of ompA. The OmpA phenotype of the mutant was verified by Western blot using polyclonal anti-OmpA antibody (5) . The mutant was termed E98.
Construction of ompA and ibeB double-deletion mutant. The ompA deletion suicide plasmid p⌬ompCm238 was transferred into the ibeB deletion mutant IB7D5 as described above. The Cm r Rif r and Km s transconjugants were selected. The double mutant, termed DK-OB, was verified by PCR for the deletion of ompA as described above, and for ibeB with primers IB7-31 and IB7-35 as described previously (7) .
Tissue cultures and in vitro invasion assays. BMEC were prepared from human brains, and invasion assays were performed as previously described (4, 6 -8) . Approximately 10 7 bacteria in 500 L of experimental medium (Ham's F12: medium 199-1 ϫ Earle salts, 5% heat-activated fetal bovine serum, 1% sodium pyruvate, 0.5% glutamine; Irvine Scientific, Santa Ana, CA, U.S.A.) were added to confluent BMEC with a multiplicity of infection of 100. The monolayers were incubated for 1.5 h at 37°C to allow invasion to occur. The number of intracellular bacteria was determined after the extracellular bacteria were killed by incubation of the monolayers with experimental medium containing gentamicin (100 g/mL) for 1 h. Results were expressed as percent invasion: [100 ϫ (number of intracellular bacteria recovered/number of bacteria incubated)].
Neonatal rat model of hematogenous E. coli K1 meningitis. E. coli bacteremia and meningitis, defined as positive CSF culture, were induced in 5-d-old rats by a previously described method (3, 8) . Briefly, outbred, specific pathogen-free, pregnant Sprague-Dawley rats with timed conception were purchased from Charles River Breeding Laboratories (Wilmington, MA, U.S.A.); the rats delivered in our vivarium 5 to 7 d after they arrived. At 5 d of age, all members of each litter were randomly divided into four groups to receive via intracardiac injection 1.0 ϫ 10 7 colony-forming units of the parent strain K12 ompA with its own promoter in pK194
This study Table 2 . Oligonucleotides used in this study
* The restriction site is underlined; the lower case letter indicates the mutant nucleotide.
† The first nucleotide of the ompA open reading frame is designated as ϩ1.
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WANG AND KIM E44, strain E98 (⌬ompA::Cm r ), strain IB7D5 (⌬ibeB), or strain DK-OB (⌬ibeB, ⌬ompA::Cm r ). Approximately 1 to 2 h after bacterial inoculation, blood and CSF specimens were obtained as described previously for quantitative cultures (3, 8) . This study was approved by the Institutional Animal Care and Use Committee.
Nucleotide sequence accession number. The sequence of ompA from E. coli K1 strain RS218 has been submitted to the GenBank database under accession number AF234269.
RESULTS
Construction of the isogenic ⌬ompA mutant of E. coli K1. The E. coli K12 ompA gene has been shown to hybridize with the ompA DNA of the K1 strain RS218, and their restriction maps were similar by Southern hybridization (13) . Therefore, the E. coli K12 DNA information was used to obtain the E. coli K1 ompA DNA by PCR. The nucleotide sequence of the K1 ompA gene revealed that, compared with the E. coli K12 ompA, 20 of 1038 nucleotides differed between the two open reading frames (98% identities). However, only three of the 325 deduced amino acid residues differ between K1 and K12 OmpA: one is in the ␤-barrel of OmpA, Ile93 (K12 strain) versus Val (K1 strain); two are in the periplasmic domain, Asn203 versus Asp, and Gly251 versus Ala.
The ompA deletion mutant, strain E91, used in our previous studies (5) was constructed from E44 by P1 transduction using the E. coli K12 strain BRE51 (⌬sulA-ompA) containing a tetracycline-resistance gene at or near the ompA locus as the donor (15) and therefore, is not an isogenic ompA deletion mutant of E44. Here, we constructed an isogenic ompA deletion mutant from E44. Three Cm r Km s transconjugants were isolated, and the lack of ompA in these colonies was verified by PCR with primers Omp3 and Omp3R. Figure 1A shows that a 2.5-kb DNA was amplified from E44 (lane 6) whereas a 2.6-kb amplicon was produced in the deletion mutants owing to the replacement of ompA with the Cm r gene (lanes 2-4). Both DNA fragments were amplified from a Cm r colony that resulted from a single crossover of p⌬ompCm238 (lane 5). OmpA-negative phenotype in the mutant was also verified by Western blot with the anti-OmpA antibodies as previously described (5) . The mutant was named E98, and its colony morphology and growth characteristics were identical to those of strain E44. The biochemical reactions were identical between E44 and E98 on the Vitek Gram-negative Identificationϩ Card (BioMerieux Vitek, Inc., Charbonnieres les Bains, France).
Similarly, an isogenic ompA deletion mutant was constructed from strain IB7D5 (⌬ibeB), and the lack of OmpA was verified by PCR and Western blot as described above (not shown). As described previously, strain IB7D5 is an isogenic in-frame ibeB deletion mutant of E44 (7). Thus, the ompA deletion mutant of strain IB7D5 represents an isogenic deletion of both ompA and ibeB, which was named DK-OB. The absence of ibeB was verified by PCR with primers IB7-31 and IB7-35 (7) (Fig. 1B) . 5) .
Noninvasive phenotype of the ompA and ibeB deletion mutants. We have previously shown that the ompA-negative mutant, E91, and the ibeB deletion mutant, IB7D5, were significantly less invasive in BMEC in vitro compared with the parent strain (5, 7). The newly constructed isogenic mutant, E98, was also shown to be significantly less invasive in BMEC than the parent strain E44 (Table 3 ). The plasmid pKE325 was constructed, which contained the E. coli K12 ompA gene with its promoter. This plasmid was able to complement strain E98 for BMEC invasion to the level of the parent strain with the vector, i.e. E44 (pK194; Table 3 ). These findings indicate that OmpA is indeed required for E. coli K1 invasion of BMEC. As expected, the ibeB deletion mutant, IB7D5, was less invasive in BMEC compared with the parent strain, E44. Of interest, when the ompA/ibeB double knockout, DK-OB, was examined for its ability to invade BMEC compared with its individual ompA and ibeB deletion mutants, its invasion capacity did not differ significantly from that of single-gene deletion mutants (Table 3) .
Prevalence of meningitis in infant rats. We next examined the single and double knockouts for their ability to invade the CNS in our well-established infant rat model of experimental hematogenesis meningitis. As shown in Table 4 , the magnitudes of bacteremia were similar among the four groups of animals. However, the occurrence of meningitis (defined as positive CSF cultures) was significantly lower (p Ͻ 0.05) in 
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OmpA AND IbeB IN E. COLI MENINGITIS animals receiving the ⌬ompA mutant, E98 (six of 22, or 27%), and the ⌬ibeB mutant, IB7D5 (five of 21, or 24%), than in those receiving the parent strain, E44 (12 of 19, or 63%). These findings with the ⌬ibeB mutant, IB7D5, were similar to those of our previous study with the noninvasive mutant 7A-33 with a single TnphoA insertion in ibeB, in which we showed that the mutant 7A-33 was significantly less able to penetrate the CNS in vivo than its parent strain (7) . Consistent with the in vitro BMEC phenotype, the prevalence of meningitis in 5-d-old rats infected with the ⌬ompA, ⌬ibeB mutant did not differ significantly from that of animals infected with the ⌬ompA or ⌬ibeB mutant. It is also important to point out that the BMEC invasion frequency of 0.1% for E. coli K1 strain E44 (Table 3) is related to enhanced invasion of the CNS in vivo (Table 4) .
DISCUSSION
OmpA is a major outer membrane protein in E. coli and is highly conserved among Gram-negative bacteria. We have previously demonstrated a novel phenotype of OmpA, i.e. its contribution to E. coli K1 invasion of BMEC in vitro (5) . This was shown by the demonstration that 1) the invasive capability of the nonisogenic ompA deletion mutant, E91, was restored to the level of the parent E. coli K1 strain by complementation with the E. coli K12 ompA gene, and 2) OmpA proteins and anti-OmpA antibodies inhibited the invasion of OmpApositive E. coli into BMEC. In the present study using an isogenic ompA-deleted mutant, we verified the role of OmpA in E. coli K1 invasion of BMEC, i.e. the isogenic ompA deletion mutant was less invasive in BMEC than its parent E. coli K1 strain and its invasive ability was restored to the level of the parent strain by complementation with the E. coli K12 ompA gene. Our sequencing analysis showed the E. coli K1 and K12 OmpAs are essentially identical. In addition, the isogenic ompA deletion mutant was significantly less able to cross the blood-brain barrier compared with the parent strain in our hematogenous meningitis animal model. These findings indicate that OmpA is indeed a critical determinant for E. coli K1 penetration into the CNS in vivo.
We have previously identified that OmpA and other E. coli factors contribute to the ability of E. coli K1 to cross the blood-brain barrier in vivo, which include Ibe proteins, TraJ, CNF1, and AslA (4 -11). We and others have also shown that these E. coli K1 genes are located at different regions of the E. coli K1 genome (3, 16, 17) . It is unclear how different invasive loci of E. coli K1 contribute to crossing of the blood-brain barrier.
Our previous investigations have revealed that E. coli K1 translocates from blood to the CNS without altering the integrity of the blood-brain barrier and transcytosis of BMEC by E. coli K1 occurs without any change in the integrity of monolayers (2, 18) . Transmission election microscopy revealed that E. coli K1 invades BMEC via a zipperlike mechanism and transmigrates through BMEC in an enclosed vacuole without intracellular multiplication (19) . E. coli K1 invasion of BMEC requires actin cytoskeletal rearrangements and induces tyrosine phosphorylation of focal adhesion kinase and paxillin, which are thought to be related to OmpA-BMEC interactions (20) . In this regard, it is important to note that OmpA interaction with the BMEC GlcNAc␤1-4 GlcNAc epitopes was shown to contribute to the traversal of E. coli K1 across the blood-brain barrier and a specific receptor for OmpA was demonstrated to be present only on BMEC (21) .
Our recent studies demonstrate that ibeA encodes an outer membrane protein with three transmembrane domains, which binds to a novel 45-kD receptor on BMEC, named Ibe10R (6, 22) . The addition of the Ibe10R protein or a polyclonal antibody raised against Ibe10R significantly inhibits E. coli K1 invasion of BMEC in vitro (16) . These findings suggest that OmpA and IbeA contribute to BMEC invasion via ligandreceptor interactions. IbeB also displays the characteristics of outer membrane proteins (7), suggesting that the IbeBmediated invasion of BMEC may also occur via a ligandreceptor interaction. We therefore speculate that OmpA and Ibe proteins might be additive or synergistic in their contributions to E. coli K1 invasion of BMEC. Because ompA and ibeB have K12 homologs (5, 6) and are more prevalent in E. coli K1 isolates from CSF compared with ibeA (7), we examined the roles of OmpA and IbeB deletions in E. coli K1 invasion of BMEC in vitro and traversal of the blood-brain barrier in vivo. We found that ⌬ompA and ⌬ibeB, alone and in combination, are, as expected, significantly less invasive in BMEC both in vitro and in vivo compared with the parent strain. We emphasize that the BMEC invasion frequency of the parent strain (approximately 0.1%) is considerably lower than the reported invasion frequency of epithelial cells by other Gram-negative bacteria such as Salmonella and Shigella species (usually 1 to 10%), but as shown here and in our previous publications (6, 8, 9) , the BMEC invasion frequency of approximately 0.1% relates to enhanced bacterial penetration through the bloodbrain barrier and thus is biologically relevant. Our unexpected finding, however, was that the invasion phenotypes of the ⌬ompA, ⌬ibeB mutant were similar to those of the single-gene deletion mutants both in vitro and in vivo.
The reasons for no additive or synergistic effect observed with the ⌬ompA, ⌬ibeB mutant are not clear. We and others have previously shown that S fimbriae consisting of the major subunit SfaA and minor subunits including SfaS are one of the major structures contributing to E. coli binding to BMEC. The two binding domains of S fimbriae have been identified, i.e. SfaS adhesin for binding to BMEC sialoglycoproteins and SfaA for binding to BMEC sulfated glycolipid (sulfatide) (23, 24) . Inasmuch as SfaS is shown to be preferentially located at the tip of S fimbriae (25), we speculate that the critical binding of S fimbriated E. coli to BMEC occurs via SfaS-BMEC sialoglycoprotein interaction, which is followed by an association of bacteria with sulfatide for a more intimate contact of organism to BMEC to withstand blood flow in vivo; such a binding is probably required for subsequent crossing of the blood-brain barrier. E. coli K1 strain RS218 (or E44) was found to possess S fimbriae, which was maintained in the ⌬ompA, ⌬ibeB mutants; thus, it is unlikely that their bindings to BMEC via S fimbriae are affected in these mutants. As described above, we anticipate finding that OmpA and IbeB interact with different receptors on BMEC, for their invasion and thus the effects of OmpA and IbeB on BMEC invasion will be at least additive. We have previously shown that E. coli K1 invasion of BMEC requires host cell actin cytoskeletal rearrangements, as shown by invasive E. coli K1-associated Factin condensation and blockade of invasion by the microfilament-disrupting agent, cytochalasin D (19) . In addition, we have shown that E. coli invasion of BMEC requires several signal transduction pathways such as focal adhesion kinase, phosphatidylinositol 3-kinase, and cytosolic phospholipase A 2 (20, 26, 27) . It remains speculative whether OmpA and IbeB interactions with their receptors involve common signaling pathways contributing to host cell actin cytoskeletal rearrangements and invasion of BMEC, thereby exhibiting no additive effects with ⌬ompA and ⌬ibeB. An alternative explanation may be that the interaction of OmpA or IbeB with its respective receptor hinders the other ligand-receptor interactions, thus eliminating any additive effect. Identification and characterization of specific BMEC receptors for OmpA and Ibe B should help clarify the observation described in this report.
